Altered protein profile in chronic myeloid leukemia chronic phase identified by a comparative proteomic study

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1764, Issue 5, 2006, Pages 929-942

  Pizzatti, Luciana ^a   Sá, Lílian Ayres ^a   de Souza, Jamison Menezes ^a,b   Bisch, Paulo Mascarello ^a   Abdelhay, Eliana ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Federal Rural of Rio de Janeiro University   (Brazil)

Author keywords

2D Electrophoresis; Chronic Myeloid Leukemia; Leukemia; MALDI TOF; Mass spectrometry; Proteomics

Indexed keywords

53BP1 PROTEIN; BCR ABL PROTEIN; CYTOPLASM PROTEIN; MORTALIN; MYC PROTEIN; OSBP RELATED PROTEIN 3; PROTEIN; PROTEIN MDMX; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS;

ADULT; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 33646703574     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.02.004     Document Type: Article

References (24)

1. Di Bacco A., Keeshan K., McKenna S.L., and Cotter T.G. Molecular Abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis. The Oncologist 5 (2000) 405-415
2. Melo J.V., Goldman J.M., and Deininger M.W.N. The molecular biology of chronic myeloid leukemia. Blood 96 (2000) 3343-3356
3. Era T., and Witte ON. Regulated Expression of p210 BCR-ABL during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1734-1737
4. Graves P.R., and Haystead T.A.J. Molecular biologist's guide to proteomics. Microbiol. Mol. Biol. Rev. 66 (2002) 39-63
5. Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature 402 (1999) 715-720
6. Wang W., Sun J., Nimtz M., Deckwer W.D., and Zeng A.P. Protein identification from two-dimensional gel electrophoresis analysis of Klebsiella pneumoniae by combined use of mass spectrometry data and raw genome sequences. Proteome Sci. (2003) 6
7. Lion T., and Gadner H. Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia 6 (1992) 495-499
8. Lion T., Prischl F., Haas A.O., Pont J., and Schwarzmeier J. Non-Radioactive detection of the rearranged BCR/ABL sequences amplified by polymerase chain reaction. Leukemia 2 (1991) 156-159
9. Beg A.A., Finco T.S., Nantermet P.V., and Baldwin Jr. A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol. Cell. Biol. 13 (1993) 3301-3310
10. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass Spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
11. Chen R., Pan S., Brentnall T.A., and Aebersold R. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol. Cell Proteomics 4 (2005) 523-533
12. Eaves C., Cashman J., and Eaves A. Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia. Leuk. Res. 22 (1998) 1085-1096
13. Laurent E., Talpaz M., Kantarjian H., and Kurzrock R. The BCR gene and Philadelphia chromosome-positive leukemogenesis. Cancer Res. 61 (2001) 2343-2355
14. Deininger M.W.N., Vieira S., Mendiola R., Schultheis B., Goldman J.M., and Melo J.V. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia. Cancer Res. 60 (2000) 2049-2054
15. Mori K., Maeda Y., Kitaura H., Taira T., et al. MM-1, a novel c-Myc-associating protein that repress transcriptional activity of c-Myc. J. Biol. Chem. 273 (1998) 29794-29800
16. Iwabuchi K., Li B., Massa H.F., Trask B.J., et al. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J. Biol. Chem. 273 (1998) 26061-26068
17. Migliorini D., Denchi E.L., Danovi D., and Jochemsen A. Mdm4 (Mdmx) regulates p-53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell. Biol. 22 (2002) 5527-5538
18. Parant J.M., and Lozano G. Disrupting TP53 in mouse models of human cancers. Human Mutat. 21 (2003) 321-326
19. Gregorio-King C.C., Collier G.R., Mc Millan J.S., and Waugh C.M. ORP-3, a human oxysterol-binding protein gene differentially expressed in hematopoietic cells. Blood 98 (2001) 2279-2281
20. Kaul S.C., Taira K., Pereira-Smith O.M., and Wadhua R. Mortalin: present and prospective. Exp. Gerontol. 37 (2002) 1157-1164
21. i ratio in cultured vascular smooth muscle cells. Circ. Res. 91 (2002) 915-922
22. Guo F., Sigua C., Bali P., George P., et al. Mechanistic role of heat shock protein 70 in BCR-ABL-mediated resistance to apoptosis in human acute leukemia cells. Blood 105 (2005) 1246-1255
23. Degot S., Hir H.L., Alpy F., Kedinger V., et al. Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module. J. Biol. Chem. 279 (2004) 33702-33715
24. Degot S., Régnier C.H., Wendling C., Chenard M.P., Rio M.C., and Tomasetto C. Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer. Oncogene 21 (2002) 4422-4434